Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion DOI Creative Commons
Prabin Baral, Nisha Bhattarai, Md Lokman Hossen

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2021, Номер 574, С. 14 - 19

Опубликована: Авг. 15, 2021

Язык: Английский

The origins of SARS-CoV-2: A critical review DOI Creative Commons
Edward C. Holmes, Stephen A. Goldstein, Angela L. Rasmussen

и другие.

Cell, Год журнала: 2021, Номер 184(19), С. 4848 - 4856

Опубликована: Авг. 19, 2021

Язык: Английский

Процитировано

454

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron DOI Creative Commons
Zhen Cui, Pan Liu, Nan Wang

и другие.

Cell, Год журнала: 2022, Номер 185(5), С. 860 - 871.e13

Опубликована: Янв. 25, 2022

The SARS-CoV-2 Omicron variant with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures the spike (S) from reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. relatively more compact domain organization confers improved stability and enhances attachment but compromises efficiency viral fusion step. Alterations in local conformation, charge, hydrophobic microenvironments underpin modulation epitopes such they are not recognized by most NTD- RBD-antibodies, facilitating immune escape. Structure S bound human ACE2, together analysis sequence conservation ACE2 binding region 25 sarbecovirus members, as well heatmaps immunogenic sites their corresponding mutational frequencies, sheds light on conserved structurally restrained regions can be used development broad-spectrum vaccines therapeutics.

Язык: Английский

Процитировано

389

Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action DOI Creative Commons
Franz X. Heinz, Karin Stiasny

npj Vaccines, Год журнала: 2021, Номер 6(1)

Опубликована: Авг. 16, 2021

COVID-19 vaccines were developed with an unprecedented pace since the beginning of pandemic. Several them have reached market authorization and mass production, leading to their global application on a large scale. This enormous progress was achieved fundamentally different vaccine technologies used in parallel. mRNA, adenoviral vector as well inactivated whole-virus are now widespread use, subunit is final stage authorization. They all rely native viral spike protein (S) SARS-CoV-2 for inducing potently neutralizing antibodies, but presentation this key antigen immune system differs substantially between categories vaccines. In article, we review relevance structural modifications S modes expression after vaccination genetic adenovirus-vector mRNA Distinguishing characteristics unknown features highlighted context protective antibody responses reactogenicity

Язык: Английский

Процитировано

352

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant DOI Creative Commons
Jun Zhang, Tianshu Xiao, Yongfei Cai

и другие.

Science, Год журнала: 2021, Номер 374(6573), С. 1353 - 1360

Опубликована: Окт. 26, 2021

Delta’s spike Understanding the molecular mechanisms of increased transmissibility and immune evasion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is critical to guiding current future intervention strategies. Zhang et al . determined cryo–electron microscopy structures full-length protein trimers Delta, Kappa, Gamma SARS-CoV-2 studied their function antigenic properties. The Delta fused membranes more efficiently at low levels cellular receptor ACE2, its pseudotyped viruses infected target cells substantially rapidly than all other tested, possibly least partly accounting for heightened transmissibility. Mutations each variant rearranged surface N-terminal domain but only caused local changes in receptor-binding domain, consistent with greater resistance neutralizing antibodies. These findings elucidate events that have led these adapt human communities evade host immunity. —VV

Язык: Английский

Процитировано

293

Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody DOI Creative Commons
Wanchao Yin, Youwei Xu, Peiyu Xu

и другие.

Science, Год журнала: 2022, Номер 375(6584), С. 1048 - 1053

Опубликована: Фев. 8, 2022

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has become the dominant infective strain. We report structures of spike trimer on its own and in complex with angiotensin-converting enzyme (ACE2) or an anti-Omicron antibody. Most mutations are located surface protein change binding epitopes to many current antibodies. In ACE2-binding site, compensating strengthen receptor domain (RBD) ACE2. Both RBD apo form thermodynamically unstable. An unusual RBD-RBD interaction ACE2-spike supports open conformation further reinforces ACE2 trimer. A broad-spectrum therapeutic antibody, JMB2002, which completed a phase 1 clinical trial, maintains neutralizing activity against Omicron. JMB2002 binds differently from other characterized antibodies inhibits binding.

Язык: Английский

Процитировано

274

Structure of SARS-CoV-2 spike protein DOI Open Access
Jun Zhang, Tianshu Xiao, Yongfei Cai

и другие.

Current Opinion in Virology, Год журнала: 2021, Номер 50, С. 173 - 182

Опубликована: Сен. 8, 2021

Язык: Английский

Процитировано

195

Molecular basis of receptor binding and antibody neutralization of Omicron DOI Open Access
Hong Qin, Wenyu Han, Jiawei Li

и другие.

Nature, Год журнала: 2022, Номер 604(7906), С. 546 - 552

Опубликована: Фев. 28, 2022

Язык: Английский

Процитировано

190

Structural diversity of the SARS-CoV-2 Omicron spike DOI Creative Commons
S. Gobeil, Rory Henderson, Victoria Stalls

и другие.

Molecular Cell, Год журнала: 2022, Номер 82(11), С. 2050 - 2068.e6

Опубликована: Март 25, 2022

Язык: Английский

Процитировано

181

Proteolytic activation of SARS‐CoV‐2 spike protein DOI Creative Commons
Makoto Takeda

Microbiology and Immunology, Год журнала: 2021, Номер 66(1), С. 15 - 23

Опубликована: Сен. 25, 2021

Spike (S) protein cleavage is a crucial step in coronavirus infection. In this review, process discussed, with particular focus on the novel coronavirus, severe acute respiratory syndrome 2 (SARS-CoV-2). Compared influenza virus and paramyxovirus membrane fusion proteins, activation mechanism of S much more complex. The has two sites (S1/S2 S2'), motif for furin protease at S1/S2 site that results from unique four-amino acid insertion one distinguishing features SARS-CoV-2. viral particle incorporates protein, which already undergone by furin, then undergoes further S2' site, mediated type II transmembrane serine (TMPRSS2), after binding to receptor angiotensin-converting enzyme (ACE2) facilitate plasma membrane. addition, SARS-CoV-2 can enter cell endocytosis be proteolytically activated cathepsin L, although not major mode variants enhanced infectivity have been emerging throughout ongoing pandemic, there close relationship between changes cleavability. All four concern carry D614G mutation, indirectly enhances cleavability furin. P681R mutation delta variant directly increases cleavability, enhancing virulence. Changes significantly impact infectivity, tissue tropism, Understanding these mechanisms critical counteracting pandemic.

Язык: Английский

Процитировано

174

Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness DOI Open Access
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith

и другие.

Nature Microbiology, Год журнала: 2022, Номер 7(5), С. 640 - 652

Опубликована: Апрель 28, 2022

Язык: Английский

Процитировано

162